Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
30 hedge funds and large institutions have $20.7M invested in Alexza Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
602% more call options, than puts
Call options by funds: $7.37M | Put options by funds: $1.05M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $5K | +$5.44K | +1,200 | New |
|
27
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $2K | +$1.86K | +411 | New |
|
28
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | +$1.99K | +439 | New |
|
29
Creative Planning
Overland Park,
Kansas
| $1K | +$680 | +150 | New |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | +$104 | +23 | New |
|
ALXA Hedge Fund Activity: Q2 2013 in Review
30 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q2 2013, worth a combined $20.7M.
Buyers outnumbered sellers: 30 funds opened new ALXA positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.
- 30 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $20.7M of Alexza Pharmaceuticals Inc stock for Q2 2013.
- 30 funds opened new Alexza Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +30 holders.
Based on aggregated 13F filings for Q2 2013.